Global Liposome Drug Delivery Market Size study, by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others), by Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, and DepoFoam Liposome Technolog

Global Liposome Drug Delivery Market Size study, by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others), by Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, and DepoFoam Liposome Technology), by Application (Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, and Photodynamic Therapy) and Regional Forecasts 2022-2028Global Liposome Drug Delivery Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Liposomes are becoming increasingly used as nano-carriers for a variety of pharmacological purposes. Phospholipid and cholesterol compositions are becoming more helpful in liposome medication delivery. Nanotechnology, on the other hand, is improving liposome medication delivery. The factors that propelled the growth of liposome drug delivery market are rise in cases of chronic conditions and increased disease control in patients suffering from colorectal cancer. For instance, as per cancer.net, in the United States, an estimated 151,030 persons will be diagnosed with colorectal cancer this year. 106,180 new cases of colon cancer and 44,850 new cases of rectal cancer were reported. Colorectal cancer is the third most often diagnosed cancer worldwide. In 2020, it is expected that 1,880,725 individuals will be diagnosed with colorectal cancer. Also, According to World Health Organization data from 2018, cardiovascular disease (CVD) was the top cause of death in Mexico in 2016, accounting for approximately 24% of all fatalities. According to the American Heart Association, cardiovascular disease (CVD) was the underlying cause of death in 840,678 fatalities in the United States in 2016. However, high costs involved in the development of drug delivery systems impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Liposome Drug Delivery Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the market share globally, owing to increasing research and development and rise in cancer prevalence in this region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate over the forecast period 2022-2028. Factors such as huge investment in research and development, rapidly aging population would create lucrative growth prospects for the Liposome Drug Delivery market across Asia-Pacific region.

Major market players included in this report are:

Spectrum Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Ipsen Pharma
Celsion Corporation
Gilead Sciences, Inc.
Astellas Pharma, Inc.
Johnson & Johnson
Luye Pharma Group
Novartis AG
Pacira BioSciences, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Liposomal Doxorubicin
Liposomal Paclitaxel
Liposomal Amphotericin B
Others
By Technology:
Stealth Liposome Technology
Non-PEGylated Liposome Technology
DepoFoam Liposome Technology
By Application:
Fungal Diseases
Cancer Therapy
Pain Management
Viral Vaccines
Photodynamic Therapy
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Liposome Drug Delivery Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Spectrum Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Ipsen Pharma
Celsion Corporation
Gilead Sciences, Inc.
Astellas Pharma, Inc.
Johnson & Johnson
Luye Pharma Group
Novartis AG
Pacira BioSciences, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.